Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Med-Aesthetics Headache Treatment Centre appears to have been a private Canadian outpatient clinic operating in Ontario, with services spanning medical aesthetics and headache treatment. Public web evidence ties the name to locations in Woodbridge and Brampton and to listings under the alternative name "MedAesthetics & The Headache Treatment Clinic." The clinic was commercially operating rather than developing proprietary therapeutics, and there is no evidence it was a biotech, pharma, or platform company. Available sources also show that Health Canada seized unauthorized Nabota Botulinum Toxin Type A connected to this clinic in 2019, and current evidence for an active operating website or corporate presence is lacking. For a biotech analyst, this should be classified as a healthcare service clinic with limited verifiable current operating information, not a drug-development company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Med-Aesthetics Headache Treatment Centre.